The gastroparesis symptoms are side effects of GLP-1s, said Dr

Back to Journals ImmunoTargets and Therapy Volume 15 Recent Advances in Vitiligo Treatment Authors Qiu Y , Su X, Chen J, Jiang S, Tang X, He Y , Liu F Received 29 October 2025 Accepted for publication 1 February 2026 Published 11 February 2026 Volume 2026:15 577653 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Sarah Wheeler Ye Qiu, Xiangxi Su, Jingru Chen, Shaojing Jiang, Xinrui Tang, Yurong He, Fang Liu Department of Dermatology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, Peoples Republic of China Correspondence: Fang Liu, Department of Dermatology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, Peoples Republic of China, Email [email protected] Purpose: This review systematically summarizes breakthrough advances in vitiligo treatment from 2020 to 2025 to provide the latest evidence-based insights for clinical practice

Education and empowerment: Helping patients understand their diagnosis, symptoms, and treatment options so they can better navigate their care
In failing or hypertrophic myocardium, increased ketone oxidation may represent adaptive fuel selection when fatty acid and glucose pathways are inefficient
The program does not guarantee a specific amount of weight loss or a particular treatment timeline
Al-Badr, in Profiles of Drug Substances, Excipients and Related Methodology, 2015 V